Stocksigma LogoStocksigma Logo

Essix Biosciences Converts Warrants into Ind-Swift Laboratories Equity Shares

Promoter group entity Essix Biosciences acquired 14.00 lakh equity shares (Rs 10 face value) of Ind-Swift Laboratories on 8th Oct'26 through the conversion

Essix Biosciences Converts Warrants into Ind-Swift Laboratories Equity Shares

Ind-Swift Laboratories Ltd 路 Acquisition/ Disposal of Shares 路 12 Oct 2026, 11:08 pm

Essix Biosciences Converts Warrants into Ind-Swift Laboratories Equity Shares Promoter group entity Essix Biosciences acquired 14.00 lakh equity shares (Rs 10 face value) of Ind-Swift Laboratories on 8th Oct'26 through the conversion of fully convertible warrants. The acquisition represents 1.58% of pre-issue and 1.49% of diluted share capital. Post-allotment, Essix Biosciences' direct holding rose to 3.43 crore shares (38.80%), while the total promoter and PAC holding increased to 43.84% of total share capital (47.18% diluted), leaving 56.00 lakh unexercised warrants. Target company paid-up equity capital expanded to Rs 88.36 crore.

Original exchange filing (PDF)

More announcements from Ind-Swift Laboratories Ltd

All Ind-Swift Laboratories Ltd announcements